MRNA or VRTX: which has stronger momentum now?
As of 2026-09-01: MRNA LONG (180 bars, uPnL +410.4%, total return +381.5%) vs VRTX LONG (72 bars, uPnL +20.8%, total return +9.2%). Momentum is the fourth gate — quality and valuation ceilings come first.
| Snapshot | 2026-09-01 · source: yahoo | |
|---|---|---|
| MRNA (Moderna) | VRTX (Vertex) | |
| Market / sector | us · Healthcare | us · Healthcare |
| Price | $142.77 | $547.29 |
| Quality score | 100/100 | 100/100 |
| Engine signal | LONG · 180 bars · uPnL +410.4% | LONG · 72 bars · uPnL +20.8% |
| Total return | +381.5% | +9.2% |
Cite this page
Balance Labs Research Desk (2026-09-01). "MRNA or VRTX: which has stronger momentum now?." balancelabs.app · https://balancelabs.app/stocks/compare/mrna-vs-vrtx/q/mrna-or-vrtx-stronger-momentum · CC BY 4.0
Ask anything
30 free credits monthly · no card required · research support, not advice
← MRNA vs VRTX · snapshot 2026-09-01 · not investment advice